Blood-Based Biomarker for Alzheimer's Disease Diagnostics...

added blog Other

2026-07-03 10:41:01 -

Blood-Based Biomarker for Alzheimer's Disease Diagnostics Market Trends in Neurodegenerative Disease Testing

The global Blood-Based Biomarker For Alzheimer’s Disease Diagnostics Market was valued at USD 169.2 million in 2025 and is projected to grow from USD 194.8 million in 2026 to USD 529.9 million by 2033, registering a CAGR of 17.4% from 2026 to 2033. North America dominated the global market with a 43.0% revenue share in 2025, driven by regulatory approvals, expanding...

0 Comments 0 Shares 3 Views 0 Reviews